Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg (Niaspan ...

The product is bioequivalent and therapeutically equivalent to the reference listing drug VYZULTA Opthalmic solution, 0.024% ...

Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Latanoprostene Bunod Ophthalmic Solution, 0.024%.

Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with ...

The pharmaceutical company has been awarded the final approval for the manufacture of Niacin Extended-Release Tablets USP in ...

In recent weeks, top health officials have floated an idea for bringing down prescription drug costs in the United States: ...

Experts have voiced concern over the safety of a popular supplement, after a woman developed a nasty vaginal infection as a ...